In vivo and ex vivo imaging of amyloid-β cascade aggregates with a Pronucleon™ peptide.

@article{Nyborg2013InVA,
  title={In vivo and ex vivo imaging of amyloid-β cascade aggregates with a Pronucleon™ peptide.},
  author={Andrew C Nyborg and Jonathan R Moll and Renee D. Wegrzyn and Daniel Havas and Birgit Hutter-Paier and Giora G Z Feuerstein and Alan S. Rudolph},
  journal={Journal of Alzheimer's disease : JAD},
  year={2013},
  volume={34 4},
  pages={957-67}
}
Accumulation of amyloid-β (Aβ) cascade aggregates is considered a hallmark of Alzheimer's disease (AD). Current dogma holds that the appearance of Aβ oligomers and larger aggregates occur many years prior to plaque formation associated with the advanced and irreparable neurocognitive decline characteristic of AD. This premise is the impetus to identify… CONTINUE READING